These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19438534)

  • 1. Magnetic resonance imaging of paronychia induced by cetuximab.
    Konheim A; Brebach E; Samuel J; Mellott A; Gandhi M; Lacouture ME
    Clin Exp Dermatol; 2009 Oct; 34(7):e258-9. PubMed ID: 19438534
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted cancer. These "smart weapons" hit cancer in novel ways.
    Held-Warmkessel J
    Nursing; 2008 Sep; 38(9):26-32. PubMed ID: 18719487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer.
    Ocvirk J; Cencelj S
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):453-9. PubMed ID: 19793151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topical steroids in the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab].
    Coquart N; Karam A; Metges JP; Misery L
    Ann Dermatol Venereol; 2010 Apr; 137(4):306-7. PubMed ID: 20417368
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment with adapalene of cetuximab-induced acneiform eruptions.
    Taguchi K; Fukunaga A; Okuno T; Nishigori C
    J Dermatol; 2012 Sep; 39(9):792-4. PubMed ID: 22168666
    [No Abstract]   [Full Text] [Related]  

  • 6. Cetuximab-induced acneiform eruption and the response to isotretinoin.
    Vezzoli P; Marzano AV; Onida F; Alessi E; Galassi B; Tomirotti M; Berti E
    Acta Derm Venereol; 2008; 88(1):84-6. PubMed ID: 18176767
    [No Abstract]   [Full Text] [Related]  

  • 7. Ecthymatous skin eruption during therapy with cetuximab.
    Navarini AA; Kamacharova I; Kerl K; Donghi D; Cozzio A
    Eur J Dermatol; 2011; 21(2):282-3. PubMed ID: 21489913
    [No Abstract]   [Full Text] [Related]  

  • 8. Rosaceiform eruption induced by cetuximab.
    Fernández-Torres R; Martínez Gomez W; Cuevas Santos J; Paradela S; Fonseca Capdevila E
    Eur J Dermatol; 2010; 20(3):392-3. PubMed ID: 20172848
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe cutaneous toxicity during concomitant radiotherapy and cetuximab treatment of head and neck cancer.
    Vano-Galvan S; de las Heras E; Harto A; Jaen P
    Eur J Dermatol; 2008; 18(4):471-2. PubMed ID: 18573734
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab-induced serum sickness.
    Schutgens RE
    Br J Haematol; 2006 Oct; 135(2):147. PubMed ID: 16869826
    [No Abstract]   [Full Text] [Related]  

  • 11. Doxycycline for the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab.
    Shu KY; Kindler HL; Medenica M; Lacouture M
    Br J Dermatol; 2006 Jan; 154(1):191-2. PubMed ID: 16403122
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cutaneous toxicity associated with cetuximab treatment in metastatic colorectal cancer].
    Rodríguez-Murphy E; Villanueva-Herraiz S; Ortega-García MP; Pérez-Feliu A; López-Montenegro Soria MA; Camps-Herrero C
    Farm Hosp; 2011; 35(3):114-20. PubMed ID: 21497124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cetuximab-induced acne.
    Molinari E; De Quatrebarbes J; André T; Aractingi S
    Dermatology; 2005; 211(4):330-3. PubMed ID: 16286741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia.
    Eames T; Grabein B; Kroth J; Wollenberg A
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):958-60. PubMed ID: 20015177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eye complications of cetuximab therapy.
    Melichar B; Nemcová I
    Eur J Cancer Care (Engl); 2007 Sep; 16(5):439-43. PubMed ID: 17760931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paronychia induced by cetuximab, an antiepidermal growth factor receptor antibody.
    Boucher KW; Davidson K; Mirakhur B; Goldberg J; Heymann WR
    J Am Acad Dermatol; 2002 Oct; 47(4):632-3. PubMed ID: 12271317
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe desquamation with skin necrosis: a distinct pattern of skin toxicity secondary to head and neck irradiation with concomitant cetuximab.
    Billan S; Abdah-Bortnyak R; Kuten A
    Isr Med Assoc J; 2008 Mar; 10(3):247. PubMed ID: 18494248
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment with oral isotretinoin of acneiform skin lesions associated with cetuximab therapy.
    Gutzmer R; Werfel T; Mao R; Kapp A; Elsner J
    Br J Dermatol; 2005 Oct; 153(4):849-51. PubMed ID: 16181478
    [No Abstract]   [Full Text] [Related]  

  • 19. StatBite: Radiation therapy plus cetuximab: skin reactions from 71 head and neck cancer patients from 11 institutions in Europe.
    J Natl Cancer Inst; 2010 Jan; 102(2):75. PubMed ID: 20054017
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy.
    Micantonio T; Fargnoli MC; Ricevuto E; Ficorella C; Marchetti P; Peris K
    Arch Dermatol; 2005 Sep; 141(9):1173-4. PubMed ID: 16172328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.